Assort Health raises $50M to automate patient calls
Assort Health, a startup using artificial intelligence to automate patient communication for specialty healthcare practices, has raised about $50 million in a Series B round at a valuation of $750 million, according to three people familiar with the deal. The financing, led by Lightspeed Venture Partners, comes just four months after the company closed its $22 million Series A.
The company develops AI-powered voice agents that handle high-volume, repetitive front desk tasks—such as scheduling, cancellations, and responding to common patient questions. By automating these interactions, Assort Health says it allows human staff to focus on more complex or sensitive patient needs.
The fresh capital arrives amid a wave of investment in AI tools designed to reduce the heavy administrative burden on healthcare offices. Just last week, EliseAI announced a $250 million Series E led by Andreessen Horowitz, valuing it at $2.2 billion, while Hello Patient secured a $20 million Series A earlier this month at a $100 million valuation, led by Scale Venture Partners.
The surge in funding reflects a broader trend: investors see patient communication as the next big area for AI adoption in healthcare, following the rapid uptake of AI-powered medical scribes from startups like Abridge and Ambience Healthcare.
Assort Health is targeting small and mid-sized specialty practices, which often struggle with long wait times and high call volumes. By speeding up responses through automation, these offices may reduce patient churn to competing practices.
Despite reporting just over $3 million in annual recurring revenue (ARR), the company is growing quickly, according to two sources. It initially focused on orthopedic and physical care offices but has since expanded into OB-GYN, dermatology, and dentistry.
Assort Health was founded two years ago by Jon Wang, a former medical student who left medicine to pursue startups, and Jeff Liu, a former Facebook engineer.
